Friday 6-13-2014 Gilead Sciences (GILD) $GILD opened at

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-13-2014 Gilead Sciences (GILD) $GILD opened at 80.68 hitting the high price of 81.10 and a day low of 79.87 with a total volume of 7,696,469. GILD had a previous close of 80.58 and has been seeing an average volume of 10,348,250.

Overall Average: 0% Hold

Recent stock forum discussions about GILD http://investorshangout.com/search?q=GILD&...mp;yt0=Go!

Shire to Conduct Trials on Vyvanse on FDA's Request - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 5:25PM CDT
Shire plc (SHPG) announced that it has agreed to conduct pediatric clinical studies following FDA's request to investigate the potential use of Vyvanse for the treatment of ADHD in children aged between 4 and 5 years. (full story)

AstraZeneca Boosts Pipeline with $232 Million Synairgen Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 5:20PM CDT
AstraZeneca (AZN) announced that it has entered into an agreement with UK-based Synairgen to in-license its respiratory disease candidate, SNG001. (full story)

Relief for Nektar after AADPAC Voting - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 5:10PM CDT
The FDA's AADPAC have recommended that no cardiovascular outcomes study is required for the PAMORA class of drugs, including Nektar's (NKTR) Movantik (full story)

Final Glance: Biotechnology companies
AP - Fri Jun 13, 5:04PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading: (full story)

Is this Gilead's Biggest Risk?
Cheryl Swanson, The Motley Fool - Motley Fool - Fri Jun 13, 4:00PM CDT
I'll get right to the punch line. Gilead Sciences revolutionary approach to hepatitis C brought in an eye-popping $2.3 billion in its first quarter. If all goes as planned, sales could reach $9 billion by 2017, on target to make Sovaldi one of... (full story)

Sanofi/ Regeneron Present Postive Data on Sarilumab - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 3:50PM CDT
Sanofi (SNY) and partner Regeneron Pharmaceuticals, Inc. (REGN) presented positive results from a phase III trial, SARIL-RA-MOBILITY, on pipeline candidate sarilumab. (full story)

J&J, ViiV Healthcare Tie Up for Single-Tablet HIV Treatment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 3:20PM CDT
ViiV Healthcare has entered into an agreement with Janssen R&D Ireland Ltd., a subsidiary of Johnson & Johnson. (full story)

Vertex Pharmaceuticals' New Kalydeco Data Out - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 3:10PM CDT
Vertex Pharmaceuticals (VRTX) announced the presentation of data from a phase III study and long-term extension studies on Kalydeco. (full story)

Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors
PR Newswire - Fri Jun 13, 2:30PM CDT
Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced the appointment of Dr. Philip Sager, MD, FACC, FAHA, FHRS, to its Board of Directors. (full story)

Could This Buyout Go Down As One of the Worst Deals Ever?
Sean Williams, The Motley Fool - Motley Fool - Fri Jun 13, 2:15PM CDT
You certainly don't have to look far these days to see that merger and acquisition activity is picking up across a number of sectors. Investors and Wall Street analysts love to see M&A activity because it signals two things. First, it points to... (full story)

Midday Glance: Biotechnology companies
AP - Fri Jun 13, 12:22PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.: (full story)

Geron Gains as FDA Lifts Partial Hold on Imetelstat Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 12:10PM CDT
While the lifting of the partial clinical hold is a step in the right direction, the full clinical hold on Geron's (GERN) imetelstat is still in place. (full story)

Bristol-Myers Suffers a Legal Setback - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 10:30AM CDT
The court rejected Bristol-Myers' appeal against a verdict issued in Feb 2013 in a patent related case involving Baraclude. (full story)

Early Glance: Biotechnology companies
AP - Fri Jun 13, 9:31AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.: (full story)

BIND Therapeutics (BIND) Soars: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 8:39AM CDT
BIND Therapeutics, Inc. (BIND) was a big mover last session, as its shares rose nearly 7% on the day. (full story)

Critical Alerts For Ralph Lauren, Rackspace Hosting, Gilead Sciences, Fortinet, and Express Scripts Technology Released By InvestorsObserver
PR Newswire - Fri Jun 13, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for RL, RAX, GILD, FTNT, and ESRX. (full story)

Sunesis Pharmaceuticals (SNSS) Soars: Stock Adds 8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 7:51AM CDT
Sunesis Pharmaceuticals, Inc. (SNSS) was a big mover last session, as its shares rose roughly 8% on the day. (full story)

Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 9.23% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 7:44AM CDT
Progenics Pharmaceuticals, Inc. (PGNX) was a big mover last session, as the company saw its shares rise over 9% on the day (full story)

Orexigen Slumps as Obesity Drug Approval Delayed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 5:28PM CDT
Orexigen announced that the FDA has delayed the action date for its obesity candidate, NB32, by three months. (full story)

Gilead Sciences Inc. (GILD) Stock Research Links

GILD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Finding Your Ideal Home Cleaning Schedule: Insights

Updated Category News Views 49

Tackling the Mess: What's Your Cleaning Game Plan? We each have our tidiness tales, but when it comes down to keeping the household shipshape, the professional cleaning schedule you pick can make all the difference. A fresh-off-the-press breakdown from HelloNation and their expert David Merreot can guide you through the choices, cutting through the clutter of confusion....

Continue Reading
Paolo Moretti: New CEO Steering RINA's Dynamic Course

Updated Category News Views 2

Leadership Shift in the Heart of RINA Today's news is a hefty dose of strategic sea change over at RINA S.p.A., where Paolo Moretti's been handed the reins as the new Group Chief Executive Officer. Now, if you haven't been following, RINA's been riding a serious wave—revenues have more than doubled in a neat five-year streak, claiming over a billion euros. So, what we...

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 3

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading
Investor Yazan Al Homsi Backs Arcanus Aerial for $500K

Updated Category News Views 96

Yazan Al Homsi Backs Canadian Innovation Every once in a while, you see a move in the market that feels bigger than the numbers on the page. That's what this $500,000 from Yazan Al Homsi into Arcanus Aerial Systems does. Al Homsi, a UAE-based investor with a solid pedigree, decided to pump half a million bucks into Arcanus just as it's setting down roots in Canadian soil...

Continue Reading
OwnATC Empowers Trainers to Expand Access to Care

Updated Category News Views 5

The Untapped Potential of Athletic Trainers In a hustle to get people's bodies moving and grooving right, we often overlook a crucial player: the Certified Athletic Trainer (CAT). These folks have been shelved in schools or sports arenas for far too long, especially when their expertise could be lighting up communities across the map. Enter OwnATC, shaking things up. A...

Continue Reading
Leviton Ignites Bridgestone Arena's Modern Makeover

Updated Category News Views 36

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Continue Reading
Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Updated Category News Views 6

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Continue Reading
Better Home & Finance Faces Class Action: What's Next?

Updated Category News Views 78

Stock Hit and Legal Drama Panic set in when Better Home & Finance Holding Company took a 28.5% nosedive after spilling some less-than-sweet news. Their promise of hitting a billion in monthly loans? Stuck in limbo as borrower trepidation reared its ugly head amidst rising rates. Investors felt the heat, watching shares skydive $12.17, landing them at a bruised $30.52. A...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 6

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading
Home Insurance Gaps: Risky Assumptions Uncovered

Updated Category News Views 43

Unseen Threats to Homeownership Safety Liability gaps in insurance are like those stubborn stains on the carpet you keep missing—nearly invisible until you're flat on your face. In Alpharetta and Fulton County, homes aren't as secure from financial pitfalls as their charming façades suggest. So, what's the danger that folks are glossing over here? Hidden Dangers of...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Snowflake's Recent Options Activity and Market Trends

Updated Category News Views 154

Uncovering Snowflake's Options Activities Recently, large financial players have shown a bullish outlook on Snowflake. A significant number of notable trades have indicated that investors are taking interest in the possibility of positive price movements for this company. An Overview of Trades Upon reviewing the options history for Snowflake (NYSE: SNOW), we identified a...

Continue Reading
Understanding Mesoblast’s U.S. Origin Designation and Benefits

Updated Category News Views 161

Mesoblast’s U.S. Origin Designation Explained In the realm of innovative healthcare, Mesoblast Limited has made significant strides as a frontrunner in allogeneic cellular medicines targeting inflammatory diseases. With its products manufactured from U.S. donors and within U.S. borders, Mesoblast proudly holds the U.S. origin designation for its allogeneic cell...

Continue Reading
Celebration of Creativity at the National Gingerbread Contest

Updated Category News Views 190

Excitement Surrounds the National Gingerbread House Competition The National Gingerbread House Competition is a beloved event that showcases remarkable baking talent and creativity. The 2025 competition at The Omni Grove Park Inn & Spa has brought immense joy, drawing participants from all corners of the nation. This year, the competition was particularly special as it...

Continue Reading
Nexans Welcomes Julien Hueber as New CEO for Growth

Updated Category News Views 886

Leadership Change at Nexans Nexans is undertaking a significant shift in leadership by appointing Julien Hueber as the new Chief Executive Officer, succeeding Christopher Guérin. This transition aims to energize the company and bolster its position in the market. Immediate Implementation of Changes The decision to bring Hueber aboard was made by the Board of Directors...

Continue Reading
SKHL: Direxion's Bold 2X Dive into Semiconductor ETFs

Updated Category News Views 9

Direxion's New Play in Memory: Betting on SK hynix Ah, the smell of leverage in the morning—nothing shakes the cobwebs quite like it. Direxion just rolled out the paperwork for their new Direxion Daily SK Hynix Bull 2X ETF, ticker SKHL if you're keeping track. It's a fresh card in the stack of high-risk, high-reward funds they've got going. If you need a reminder,...

Continue Reading